Results 271 to 280 of about 390,856 (338)

Efficacy and safety of anifrolumab across organ domains of systemic lupus erythematosus: A systematic review and meta‐analysis

Rheumatology &Autoimmunity, EarlyView.
A systematic review and meta‐analysis were conducted to review all clinical trial results of anifrolumab for treating systemic lupus erythematosus. Fourteen studies were included comprising 1322 patients and five studies were meta‐analyzed. It was found that anifrolumab 300 mg IV led to clinical improvement across composite lupus scores, cutaneous ...
Yomna W. Mahmoud, Mohamed Ramadan S., Doaa Radwan G., Mariam S. Abdulhafiz, Yassin M. El‐Shnawy, Alaa Alaa H., Sara Naser Sebie, Maryam A. Elashmawi, Husni Zahi M., Mohammad T. Abuawwad, Mohammad J. Taha, Abdulqadir J. Nashwan   +11 more
wiley   +1 more source

Refractory Lupus Podocytopathy: The Role of Repeat Biopsy and Rituximab. [PDF]

Cureus
Shan HY.
europepmc   +1 more source

Research progress in the application of single‐cell sequencing technology in rheumatic diseases

Rheumatology &Autoimmunity, EarlyView.
Application of single‐cell RNA sequencing (scRNA‐seq) technology in the study of the pathogenesis of rheumatic diseases. Tree of content illustration depicting the multi‐layered insights from scRNA‐seq in rheumatic diseases. The outer layer highlights key cell subsets identified by scRNA‐seq in rheumatoid arthritis, systemic lupus erythematosus ...
Xinzhe Feng, Zhou Ji, Changhao Han, Zhi Li, Chenxu Liu, Weidong Xu   +5 more
wiley   +1 more source

The Targets of Immune Adverse Events in Cancer Immunotherapy by Combined Check-point Inhibitors Resemble those Seen in IPEX Patients. [PDF]

J Clin Immunol
Moraes-Fontes MF, Demengeot J, Coutinho A.   +2 more
europepmc   +1 more source

Neutrophil-to-lymphocyte ratio and CD40 as diagnostic biomarkers for systemic lupus erythematosus and its disease activity. [PDF]

Am J Transl Res
Wang J, Zhang R, Guo Y, Zhai X, Liu J.
europepmc   +1 more source

Frozen in Addiction: A New Wave of Drug‐Induced Movement Disorders?

Movement Disorders, EarlyView.
Christos Ganos, Roberto Erro, Mohammad Abdullah, Tanya S. Hauck, Daniel Ciccarone, Christy Sutherland, Parisa Saiyarsarai, Connie Marras, Susan H. Fox, Alfonso Fasano, Anthony E. Lang, Jonathan Squires, Kailash P. Bhatia   +12 more
wiley   +1 more source

The Effects of Exercise Training on Functional Aerobic Capacity and Quality of Life in Patients with Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials. [PDF]

J Clin Med
Zouganeli V, Dimopoulos S, Briasoulis A, Karkamanis A, Panagiotopoulos P, Karatzanos E, Boumpas DT, Vasileiadis I, Nanas S, Kourek C.   +9 more
europepmc   +1 more source

Ptosis: an uncommon manifestation to autoimmune disease activity in systemic lupus erythematosus. [PDF]

BMC Ophthalmol
Al-Battashy A, Ghaithi HA, Al Lawati BS, Al-Mujaini AS.   +3 more
europepmc   +1 more source

Lupus nephritis in Africa: a systematic review of case reports and case series. [PDF]

BMC Nephrol
Jayte M, Mohamed AA, Karshe A, Abdi AA, Hassan HA.   +4 more
europepmc   +1 more source

Correction: A Scoping Review of the Positive and Negative Bacteria Associated With the Gut Microbiomes of Systemic Lupus Erythematosus Patients. [PDF]

Cureus
McPhail MN, Wu M, Tague K, Wajeeh H, Demory Beckler M, Kesselman MM.   +5 more
europepmc   +1 more source